Skin lesions in plasmacytoid dendritic cell leukaemia.
Whittle
Annika M
AM
Department of Haematology, York Hospital, York, UK.
Howard
Martin R
MR
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003713:Dendritic Cells / Q000473:pathology*; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000188:drug therapy / Q000473:pathology*; D017254:Leukemic Infiltration / Q000473:pathology*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012867:Skin / Q000473:pathology*; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone